Applying Lyon Consensus criteria in the work-up of patients with proton pump inhibitory-refractory heartburn
- PMID: 35229321
- DOI: 10.1111/apt.16838
Applying Lyon Consensus criteria in the work-up of patients with proton pump inhibitory-refractory heartburn
Abstract
Background: A hierarchical approach for gastro-oesophageal reflux disease (GERD) diagnosis by impedance-pH monitoring was proposed by the Lyon Consensus, based on acid exposure time (AET) and supportive impedance metrics.
Aims: To establish the clinical value of Lyon Consensus criteria in the work-up of patients with proton pump inhibitory (PPI)-refractory heartburn.
Methods: Expert review of off-therapy impedance-pH tracings from unproven GERD patients with PPI-refractory heartburn prospectively evaluated at referral centers. Impedance metrics, namely total reflux episodes, postreflux swallow-induced peristaltic wave index, and mean nocturnal baseline impedance, were assessed. Expert review of on-therapy preoperative impedance-pH tracings from a separate cohort of surgically treated erosive/nonerosive GERD cases.
Results: Off-therapy, normal, inconclusive, and abnormal AET was found in 59%, 17%, and 23% of 317 cases. Supportive evidence of GERD was provided by abnormal impedance metrics in up to 22% and 62% of cases in the normal and inconclusive AET groups, respectively. Adding the cases with inconclusive AET and abnormal impedance metrics to the abnormal AET group, a significant increase in GERD evidence was observed (from 23% to 37% of cases, p < 0.0002). At the on-therapy presurgical evaluation, abnormal/inconclusive AET and supraphysiological values of impedance metrics showed ongoing reflux in 21% and 90% of 96 cases, respectively (p < 0.00001); a relationship between on-therapy ongoing reflux and PPI-refractory heartburn was confirmed by the favorable surgical outcome at 3-year follow-up, 88% of cases being in persistent off-PPI heartburn remission.
Conclusions: Impedance-pH monitoring, off- and on-therapy, is of high clinical value in the work-up of patients with PPI-refractory heartburn.
Keywords: GERD; PPI; impedance-pH monitoring; laparoscopic fundoplication.
© 2022 John Wiley & Sons Ltd.
Comment in
-
Editorial: Lyon consensus metrics-towards personalised diagnosis of non-erosive reflux disease.Aliment Pharmacol Ther. 2022 May;55(9):1214-1215. doi: 10.1111/apt.16899. Aliment Pharmacol Ther. 2022. PMID: 35429030 No abstract available.
-
Editorial: Lyon consensus metrics-towards personalised diagnosis of non-erosive reflux disease: Authors' reply.Aliment Pharmacol Ther. 2022 May;55(9):1216-1217. doi: 10.1111/apt.16911. Aliment Pharmacol Ther. 2022. PMID: 35429031 No abstract available.
References
REFERENCES
-
- Kahrilas P, Shaheen N, Vaezi M. American Gastroenterological Association Institute technical review on the management of gastroesophageal reflux disease. Gastroenterology. 2008;135:1392-1413.
-
- Katz P, Gerson L, Vela M. Guidelines for the diagnosis and management of gastroesophageal reflux disease. Am J Gastroenterol. 2013;108:308-328.
-
- Yadaplati R, Vaezi MF, Vela MF, Spechler SJ, Shaheen NJ, Richter J, et al. Management options for patients with GERD and persistent symptoms on proton pump inhibitors: recommendations from an expert panel. Am J Gastroenterol. 2018;113:980-986.
-
- Vaezi MF, Sifrim D. Assessing old and new diagnostic tests for gastroesophageal reflux disease. Gastroenterology. 2018;154:289-301.
-
- Gyawali CP, Kahrilas PJ, Savarino E, Zerbib F, Mion F, Smout AJPM, et al. Modern diagnosis of GERD: the Lyon Consensus. Gut. 2018;67:1351-1362.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical